Page 117 - 南京医科大学自然版

第44卷第10期 陈萌萌，高珂梦，沈 楠，等. PET/MRI在头颈部肿瘤中的应用价值［J］.
2024年10月 南京医科大学学报（自然科学版），2024，44（10）：1428⁃1434 ·1433 ·

［24］YEH C H，CHAN S C，LIN C Y，et al. Comparison of（18） Prognostic value of PET/CT and MR⁃based baseline ra⁃
F⁃FDG PET/MRI，MRI，and（18）F⁃FDG PET/CT for the diomics among patients with non⁃metastatic nasopharyn⁃
detection of synchronous cancers and distant metastases geal carcinoma［J］. Front Oncol，2022，12：952763
in patients with oropharyngeal and hypopharyngeal squa⁃ ［37］HUANG C，ZHANG L，MENG Z，et al. Prognostic value
mous cell carcinoma［J］. Eur J Nucl Med Mol Imaging， of F⁃fluorodeoxyglucose⁃positron emission tomography/
18
2020，47（1）：94-104 magnetic resonance imaging in patients with hypopharyn⁃
［25］COCA⁃PELAZ A，RODRIGO J P，SUAREZ C，et al. The geal squamous cell carcinoma［J］. J Comput Assist To⁃
risk of second primary tumors in head and neck cancer：a mogr，2022，46（6）：968-977
systematic review［J］. Head Neck，2020，42（3）：456-466 ［38］CHAN S，YEH C，NG S，et al. Prospective investigation of
［26］NG S P，POLLARD C，KAMAL M，et al. Risk of second 18 FDG⁃PET/MRI with intravoxel incoherent motion diffu⁃
primary malignancies in head and neck cancer patients sion⁃weighted imaging to assess survival in patients with
treated with definitive radiotherapy［J］. NPJ Precis Oncol， oropharyngeal or hypopharyngeal carcinoma［J］. Cancers，
2019，3（1）：22 2022，14（24）：6104
［27］DAHLSGAARD ⁃ WALLENIUS S E，HILDEBRANDT M ［39］RASMUSSEN J H，NORGAARD M，HANSEN A E，et al.
G，JOHANSEN A，et al. Hybrid PET/MRI in non⁃small Feasibility of multiparametric imaging with PET/MR in
cell lung cancer（NSCLC）and lung nodules⁃a literature head and neck squamous cell carcinoma［J］. J Nucl Med，
review［J］. Eur J Nucl Med Mol Imaging，2021，48（2）： 2017，58（1）：69-74
584-591 ［40］SAMOLYK⁃KOGACZEWSKA N，SIERKO E，ZUZDA K，
［28］RAAD R A，FRIEDMAN K P，HEACOCK L，et al. Out⁃ et al. PET/MRI⁃guided GTV delineation during radiother⁃
come of small lung nodules missed on hybrid PET/MRI in apy planning in patients with squamous cell carcinoma of
patients with primary malignancy［J］. J Magn Reson Imag⁃ the tongue［J］. Strahlenther Onkol，2019，195（9）：780-
ing，2016，43（2）：504-511 791
［29］ZENG F，NOGAMI M，UENO Y R，et al. Diagnostic per⁃ ［41］SATO J，KITAGAWA Y，WATANABE S，et al.（18）F⁃Flu⁃
formance of zero⁃TE lung MR imaging in FDG PET/MRI oromisonidazole positron emission tomography（FMISO ⁃
for pulmonary malignancies［J］. Eur Radiol，2020，30 PET）may reflect hypoxia and cell proliferation activity in
（9）：4995-5003 oral squamous cell carcinoma［J］. Oral Surg Oral Med
［30］SEKINE T，BARBOSA F G，SAH B R，et al. PET/MR out⁃ Oral Pathol Oral Radiol，2017，124（3）：261-270
18
performs PET/CT in suspected occult tumors［J］. Clin Nucl ［42］CARLES M，FECHTER T，GROSU A L，et al. F⁃FMISO⁃
Med，2017，42（2）：e88-e95 PET hypoxia monitoring for head ⁃ and ⁃ neck cancer pa⁃
［31］WANGARYATTAWANICH P，AGARWAL M，RATH T tients：radiomics analyses predict the outcome of chemo⁃
J. PET/CT and PET/MRI evaluation of post ⁃ treatment radiotherapy［J］. Cancers，2021，13（14）：3449
head and neck［J］. Semin Roentgenol，2023，58（3）：331- ［43］IMAIZUMI A，OBATA T，KERSHAW J，et al. Imaging of
346 hypoxic tumor：correlation between diffusion ⁃ weighted
18
［32］KIM E S，YOON D Y，MOON J Y，et al. Detection of loco⁃ MR imaging and F⁃fluoroazomycin arabinoside positron
regional recurrence in malignant head and neck tumors：a emission tomography in head and neck carcinoma［J］.
comparison of CT，MRI，and FDG PET⁃CT［J］. Acta Radi⁃ Magn Reson Med Sci，2020，19（3）：276-281
ol，2019，60（2）：186-195 ［44］WACK L J，MONNICH D，VAN ELMPT W，et al. Compari⁃
［33］PATEL L D，BRIDGHAM K，CIRIELLO J，et al. PET/MR son of［18F］⁃FMISO，［18F］⁃FAZA and［18F］⁃HX4 for
imaging in evaluating treatment failure of head and neck PET imaging of hypoxia⁃⁃a simulation study［J］. Acta On⁃
malignancies：a neck imaging reporting and data system⁃ col，2015，54（9）：1370-1377
based study［J］. Am J Neuroradiol，2022，43（3）：435-441 ［45］SANDULEANU S，HAMMING⁃VRIEZE O，WESSELING
［34］HOFFMAN R M. L⁃Methyl⁃（11）C methionine⁃positron⁃ F W R，et al.［18F］⁃ HX4 PET/CT hypoxia in patients
emission tomography（MET⁃PET）［J］. Methods Mol Biol， with squamous cell carcinoma of the head and neck treat⁃
2019，1866：267-271 ed with chemoradiotherapy：prognostic results from two
［35］PACE L，NICOLAI E，CAVALIERE C，et al. Prognostic prospective trials［J］. Clin Transl Radiat Oncol，2020，23：
18
valueof F⁃FDGPET/MRIinpatientswithadvancedoropha⁃ 9-15
ryngeal and hypopharyngeal squamous cell carcinoma［J］. ［46］PELTANOVA B，RAUDENSKA M，MASARIK M. Effect
Ann Nucl Med，2021，35（4）：479-484 of tumor microenvironment on pathogenesis of the head
［36］KULANTHAIVELU R，KOHAN A，HINZPETER R，et al. and neck squamous cell carcinoma：a systematic review［J］.